Simon Dazhong Lu
Director/Board Member at ASCENTAGE PHARMA GROUP INTERNATIONAL
Net worth: - $ as of 29/04/2024
Profile
Simon Dazhong Lu is a Non-Executive Director at Ascentage Pharma Group International Co., Ltd.
He was previously a Director at McGill University, Managing Director at CEL Partners Co. Ltd., and Partner & Investment Manager at Shanghai NewMargin Ventures Investment Management Co. Ltd.
He also worked as an Auditor at Arthur Andersen Business Consulting Co. Ltd.
(Shanghai).
Lu holds a doctorate degree from Nankai University, which he received in 2010, and an undergraduate degree from the same university, which he received in 1991.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 29/06/2023 | 0 ( -.--% ) | - $ | 29/04/2024 |
Simon Dazhong Lu active positions
| Companies | Position | Start |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Director/Board Member | 05/07/2018 |
Former positions of Simon Dazhong Lu
| Companies | Position | End |
|---|---|---|
| McGill University | Director/Board Member | 31/10/2018 |
CEL Partners Co. Ltd.
 CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Chief Executive Officer | 30/06/2009 |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
 Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Chief Investment Officer | 30/11/2007 |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) | Comptroller/Controller/Auditor | - |
Training of Simon Dazhong Lu
| Nankai University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Health Technology |
| Private companies | 3 |
|---|---|
CEL Partners Co. Ltd.
CEL Partners Co. Ltd. Investment ManagersFinance CEL Partners is an independent China-based private equity firm which was established in 2007 to manage China Equity Links SAS, the first independent continental Europe private equity fund dedicated to investments in China. Based in Beijing, CEL Partners is comprised of Chinese and Western professionals, complemented by a team of Senior Advisors. The China Equity Links fund is backed by global financial institutions including Crédit Agricole, Société Générale, Caisse des Dépôt et des Consignations, Savings Bank Group, CNP, Groupama and Scor and has an office in Paris, France. | Finance |
Shanghai NewMargin Ventures Investment Management Co. Ltd.
Shanghai NewMargin Ventures Investment Management Co. Ltd. Investment ManagersFinance Shanghai NewMargin Ventures Investment Management Co. Ltd. is an Independent Venture Capital firm founded in 1999 by Tao Feng. Shanghai NewMargin Ventures Investment Management Co. Ltd. is headquartered in Shanghai. | Finance |
| Arthur Andersen Business Consulting Co. Ltd. (Shanghai) |
- Stock Market
- Insiders
- Simon Dazhong Lu
